These ten stocks, not just from tech, are the key to next year's S&P 500 earnings growthMarket Watch • 11/21/23
Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers third sales milestone payment for the region from Pfizer this yearGlobeNewsWire • 11/20/23
Serina Therapeutics Announces POZ Polymer Technology License Agreement with PfizerGlobeNewsWire • 11/17/23
Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment SettingPRNewsWire • 11/17/23
AbbVie and Pfizer Have 1 Thing in Common: Their Biggest Products Are on the Decline. Time to Sell?The Motley Fool • 11/16/23
Is Pfizer Stock A Sell After Its Covid Sales 'All But Disappeared'?Investors Business Daily • 11/15/23
Employer coverage of GLP-1 drugs for weight loss lags far behind diabetes coverage, survey findsMarket Watch • 11/14/23